Sumitomo Mitsui Trust Holdings Inc. Decreases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sumitomo Mitsui Trust Holdings Inc. lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 87.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 67,499 shares of the medical instruments supplier’s stock after selling 457,064 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $2,402,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. VisionPoint Advisory Group LLC lifted its stake in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares in the last quarter. Anchor Investment Management LLC purchased a new stake in DENTSPLY SIRONA in the 4th quarter worth $47,000. Exchange Traded Concepts LLC lifted its stake in DENTSPLY SIRONA by 41.2% in the 3rd quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 439 shares in the last quarter. Creative Financial Designs Inc. ADV purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at about $71,000. Finally, CWM LLC raised its position in shares of DENTSPLY SIRONA by 85.5% during the 3rd quarter. CWM LLC now owns 4,379 shares of the medical instruments supplier’s stock valued at $150,000 after buying an additional 2,018 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $30.92 on Thursday. The company has a market capitalization of $6.41 billion, a price-to-earnings ratio of -49.87, a PEG ratio of 1.23 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12 month low of $26.27 and a 12 month high of $43.24. The firm’s 50-day moving average is $32.70 and its 200 day moving average is $32.81. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.46 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio is currently -103.22%.

Analyst Ratings Changes

Several brokerages have recently issued reports on XRAY. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. SVB Leerink began coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 target price on the stock. Needham & Company LLC restated a “buy” rating and set a $42.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Piper Sandler upped their target price on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Friday, January 12th. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $39.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.